pdufa.bio
CalendarConferencesAdCommDecisionsReadoutsResearchAccount
Home › PDUFA Calendar › ARQT

ARQT FDA calendar & decision history

Arcutis · 1 upcoming · 4 past FDA decisions

Upcoming FDA catalysts

ARQT · Feb 23, 2027FDA decision

FDA decision history (4)

Jun 30, 2026✓ ApprovedZORYVE (roflumilast) Cream 0.3Jun 29, 2026✓ ApprovedZORYVE (roflumilast) cream 0.3% approved forOct 6, 2025✓ ApprovedFDA decisionMay 22, 2025✓ ApprovedFDA decision
Full PDUFA calendar →All FDA decisions →Phase readouts →
See the full 2026 PDUFA calendar →

This page aggregates ARQT's FDA catalysts from pdufa.bio's own calendar and decision archive. Each item links to its source page. Facts and dates only; verify against primary FDA / SEC / company filings.